Seeking men and women whose head and neck cancer has progressed following immune checkpoint inhibitor treatment for a study of an investigational drug combination.
Participants in this study will be assigned to get one of three different drug combinations for up to two years. After treatment, participants will get follow-up phone calls for an additional three years.
What we're hoping for
We are comparing three different drug combinations for head and neck cancer that has progressed following treatment with an immune checkpoint inhibitor to see if one is better than the other.
ClinicalTrials.gov Identifier: NCT05063552